Category: Include on Menu
-
Trump’s Delay Of EU Tariffs Sparks Rally On Wall Street
After moving sharply higher early in the session, stocks saw further upside over the course of the trading day on Tuesday. With the strong upward move, the major averages largely offset the steep losses posted last week. The Nasdaq shot up 461.96 points or 2.5 percent to 19,199.16, the S&P 500 (SPI:SP500) surged 118.72 points…
-
NeuroPace Shares Plunge After Mixed Clinical Trial Results
NeuroPace Inc. (NASDAQ:NPCE) saw its stock nosedive by 36.1% today after announcing that its NAUTILUS clinical trial failed to meet its primary effectiveness target across the full patient population. The study was aimed at assessing the RNS System as a treatment for drug-resistant idiopathic generalized epilepsy (IGE). Despite the disappointing topline efficacy results, the study…
-
Eos Energy Shares Drop 10% Following Sudden CFO Departure
Shares of Eos Energy Enterprises Inc. (NASDAQ:EOSE) fell sharply by 10.1% after the abrupt termination of CFO Eric Javidi was announced on May 27, 2025. The company emphasized that Javidi’s departure was “without cause” and unrelated to any financial discrepancies or disagreements. He is expected to receive severance in line with his offer letter. Despite…
-
Eli Lilly Expands Pain Treatment Pipeline with SiteOne Therapeutics Acquisition
Eli Lilly and Company (NYSE:LLY) is advancing its neuroscience portfolio by acquiring SiteOne Therapeutics in a deal valued at up to $1 billion, reinforcing its focus on non-opioid pain therapies. The acquisition centers on SiteOne’s STC-004, a Phase 2-ready Nav1.8 inhibitor designed to provide relief for chronic pain sufferers without the risks of addiction associated…
-
Strategy Shares Gain After Major Bitcoin Purchase
Shares of Strategy (NASDAQ:MSTR), the Bitcoin-focused company led by Michael Saylor, rose 3.6% in premarket trading following news of a substantial Bitcoin acquisition. On Monday, Strategy revealed it had acquired an additional 4,020 Bitcoins at a total cost of $427.1 million. This purchase was financed through the sale of at-the-market perpetual strike preferred stock. This…
-
Rocket Pharmaceuticals Shares Plunge After Patient Death Leads to Trial Suspension
Rocket Pharmaceuticals (NASDAQ:RCKT) saw its stock tumble 57% in premarket trading after reporting a patient death linked to serious adverse effects during a clinical trial. This tragic incident has triggered an in-depth investigation and ongoing discussions with the FDA as the company works to determine the cause of the complication. The patient’s passing was associated…
-
JPMorgan Adopts Bullish Outlook on Crypto Amid Positive Sector Developments
JPMorgan has shifted to a more optimistic stance on digital assets, pointing to several factors that may support growth throughout 2025. “We turn more constructive on digital assets,” strategists led by Nikolaos Panigirtzoglou stated in a Monday note, marking a change after subdued results from crypto hedge funds and CTAs earlier this year. A major…
-
JPMorgan: S&P 500 Likely to Climb 300 Points After Brief Pullback
Despite a recent dip in U.S. equities, JPMorgan analysts anticipate that the S&P 500’s next significant move will be upward. “The SPX fell 2.6% last week, trimming the MTD gain to 4.2% and pushing the YTD return back into negative territory, -1.3%,” the firm noted. However, they view this decline as a temporary correction rather…
-
Morgan Stanley: 25% Tariff Unlikely to Prompt Apple to Relocate iPhone Production to U.S.
Morgan Stanley analysts believe a 25% import tariff on iPhones won’t be enough to compel Apple Inc. (NASDAQ:AAPL) to move its iPhone manufacturing back to the United States. “While ‘time to market’ of a U.S.-produced iPhone is one major impediment, our math says a 25% tariff on iPhone imports isn’t enough incentive for Apple to…
-
SoundHound Shares Rise After Piper Sandler Initiates Coverage With Bullish Outlook
SoundHound AI (NASDAQ:SOUN) saw its stock climb 5% in premarket trading Tuesday after Piper Sandler initiated coverage with an Overweight rating and a price target of $12. The investment firm described the voice-AI company as a “direct play on the A.I revolution,” thanks to its robust conversational technology. Piper Sandler’s analysts highlighted SoundHound’s architecture—which combines…